Dr. Marty Makary had just finished his last surgery at Johns Hopkins when he stepped into one of the most powerful roles in ...

The U.S. government is putting down $500 million toward the development of a “universal” vaccine—a shot designed to protect ...

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

On May 1, the U.S. Department of Health and Human Services (HHS) and the National Institutes of Health (NIH) announced the ...

The U.S. Department of Health and Human services says it will require all new vaccines to be tested in placebo-controlled ...

Former intelligence office and Air Force Maj. Kacy Dixon tells her story about her separation from the military after defying ...

On a Thursday conference call with investors, Moderna CFO Jamey Mock outlined a roadmap for the mRNA specialist to lower its ...

The new policy, revealed by the Department of Health and Human Services on Wednesday, would make vaccines “less available and ...

Kennedy and FDA Commissioner Marty Makary’s approach to assessing vaccines could put Covid boosters out of reach.

Jefferies analysts said Moderna’s first quarter was “in line,” with a miss on revenue offset by a beat on earnings per share.

From STAT’s Jason Mast: Moderna said this morning in its earnings report it planned to cut costs by around $1.5 billion by ...

“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...